{"id":"W2151979638","doi":"10.1634/theoncologist.10-5-345","title":"HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes from the HER1/EGFR Inhibitor Rash Management Forum","year":2005,"lang":"en","type":"review","venue":"The Oncologist","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Rash; Medicine; Dermatology; Acne; EGFR inhibitors; Adverse effect; Etiology; Epidermal growth factor receptor; Pathology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001742594,0.0008477163,0.002094452,0.0002196557,0.0008607135,0.00021942,0.0008134564,0.0007210657,0.0001195286],"category_scores_gemma":[0.0003768025,0.0004593384,0.0007415533,0.0007671631,0.0007497151,0.0001178279,0.0008779916,0.001006151,0.0001337487],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02464092,"about_ca_system_score_gemma":0.001710903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007082001,"about_ca_topic_score_gemma":0.00202077,"domain_scores_codex":[0.9952219,0.0006560895,0.00118668,0.001000334,0.0009616412,0.0009733287],"domain_scores_gemma":[0.9954547,0.00199912,0.0007255999,0.001382029,0.0001723335,0.0002662195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008916452,0.0002956603,0.0001664224,0.004670236,0.00283228,0.00008559924,0.0003188115,0.000002887964,4.574006e-7,0.0009735762,0.1546518,0.8359131],"study_design_scores_gemma":[0.008315518,0.0001924832,0.0006919724,0.004983954,0.004231035,0.0000406461,0.001298453,0.00008448099,0.000002181252,0.0004009621,0.9792988,0.000459528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004299894,0.9668371,0.00003665835,0.01599333,0.001892872,0.01082411,0.0003028295,0.0002890661,0.003394047],"genre_scores_gemma":[0.0003203413,0.9710605,0.0008466061,0.001818704,0.002833218,0.002669672,0.0009517524,0.0001606165,0.01933862],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8354536,"threshold_uncertainty_score":0.9997858,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06765387642643766,"score_gpt":0.3690442441056063,"score_spread":0.3013903676791686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}